Egilius L.H. Spierings, MD, PhD

Boston Headache Institute

Dr. Spierings is a graduate of the Erasmus University in Rotterdam, The Netherlands, where he received his M.D.-degree in 1978 and his Ph.D.-degree in experimental pharmacology in 1980. As a Ph.D.-student in pharmacology, he validated the animal experimental migraine model that was subsequently used by Glaxo to develop sumatriptan. He trained in neurology at the University Hospital Dijkzigt in Rotterdam, The Netherlands, with extensive training in neurosurgery and psychiatry. He trained in headache management with John R. Graham, M.D., at The Headache Research Foundation in Boston, MA. In 1986, he succeeded Dr. Graham as director of The Headache Research Foundation and in 1987, he founded the John. R. Graham Headache Centre. He was the director of the Dr. Spierings has been involved in headache research since he was a medical student, now over 40 years ago. He has been involved in headache management since he became a neurologist in 1985. His neurological practice has always been dedicated to headache and face pain. He described hemicrania continua as an indomethacin-responsive headache syndrome, developed the high-dose verapamil treatment of cluster headache, and conceptualized the parallel theory of migraine pathogenesis. More recently, his interest has been in the comorbidities of chronic migraine for which he coined the term, systemic endocrine-metabolic disorder.